Click here to view this email on your mobile device
View this email in your Web browser: http://whatcounts.jobson.com/dm?id=%%SUBSCRIBER_ID_TAG%%
November 20, 2014
VMail Technology
www.visionmonday.com   Facebook Twitter
In This Edition

EXAMS / DISPENSING

i-Lid Cleanser Proves Effective

WEB TECH

Opti-Port Debuts CLX 2.0

TOOLS / SUPPLIES

OptiSource’s Job Tray Cleaner

EXAMS / DISPENSING

New Study Shows Effectiveness of i-Lid Cleanser


More Images
Product: i-Lid Cleanser
Top Line: The Eye Institute, located in Marin County, Calif., recently announced that an informal nationwide survey of eye doctors and patients shows success with the use of a recently launched product, i-Lid Cleanser from NovaBay Pharmaceuticals, to treat Evaporaive Dry Eye Syndrome associated with Blepharitis and Meibomian Gland Dysfunction. The condition is the result of over-colonization of Staph bacteria, resulting in inflammation of eye lids and blockage of meibomian glands that help lubricate the eye surface. “We’re finding this innovative product has had significant impact in helping many patients,” said Kathryn Najafi-Tagol, MD, founder and medical director of the Eye Institute.
Close Up: i-Lid Cleanser has broad in-vitro antimicrobial activity and has been cleared by the FDA as a skin and wound cleanser. i-Lid Cleanser maintains its antimicrobial activity by the use of NovaBay’s proprietary ingredient, Neutrox, which contains the same active ingredient used by white blood cells as their first line of defense against bacteria and other microbial invaders. Lab tests show Neutrox not only kills bacteria, it also neutralizes the bacterial toxins that contribute to blepharitis and another condition called dry eye syndrome.
Vital Stats: The active ingredient in i-Lid Cleanser is a proprietary pure and stable form of hypochlorous acid or HOCI. HOCI is a bacterial component of the innate immune system. Incorporation into a commercial product required Dr. Najafi-Tagol to engineer a forumulation that would maintain the stability of the acid and avoid other impurities. Results from pharmaceutical laboratory studies conducted by NovaBay Pharmaceuticals in coordination with Dr. Najafi-Tagol's Eye Institute evaluating the stabilized hypochlorous acid proved that it has fast-acting, broad-spectrum activity against microorganisms found in the external ocular flora plus the ability to disrupt biofilm that harbors bacteria. Dr. Najafi-Tagol's testing also established that i-Lid Cleanser is non-toxic to human tissues, non-irritating, and hypoallergenic.
i-Lid Cleanser is available by prescription only. It comes in a 40ml glass bottle with a fine mist spray pump included. The product has recently been added to the Vision Source Network, and is also available through local pharmacies and major retail chains across the U.S., such as Wal-Mart, Costco, CVS and Target, through a distribution agreement between NovaBay Pharmaceuticals and McKesson Corp. Click here to see a video about i-Lid Cleanser.
www.ilidcleanser.com; (800) 890-0329


Top Send your comments to VM

WEB TECH

CLX Upgrade Improves Contact Lens Ordering, Reporting Capability, Inventory, and Return Processing


Product: CLX 2.0
Top Line: Opti-Port is releasing the latest version of its CLX contact lens management system.
Close Up: The upgraded system, CLX 2.0, streamlines contact lens ordering and introduces a new inventory and return module, practice and doctor benchmarking reports, and national comparative pricing analysis.
“The CLX System was originally designed to reduce contact lens administration time and allow eyecare practices to better manage their contact lens business,” said Jim Edwards, president of Opti-Port. “The improved features of CLX 2.0 will further allow our users to profitably build and grow their contact lens business, one of the most vital areas of a practice in today’s optical industry landscape.” The updated CLX System is said to not only simplify contact lens ordering, inventory and returns, but also to provide robust reporting on key metrics such as annual supply percentage, national retail pricing comparisons, sales by product modalities, and product usage by doctor or office location. This reporting functionality can provide practice owners and operators access to real-time data on which to continuously evaluate their contact lens businesses.
Vital Stats: Opti-Port’s CLX System is a cloud-based management platform specifically designed to improve the efficiency and accuracy of contact lens administration as well as to provide valuable data and robust metrics reporting.
www.CLXsystem.com; (314) 743-0781

For more on Ordering and Inventory, visit VM’s Intelligent Office

Top Send your comments to VM

TOOLS / SUPPLIES

OptiSource Intros Job Tray Cleaner


Product: Job Tray Cleaner
Top Line: OptiSource has developed a first-of-its-kind solution that removes dried polish from job trays, and restores them to like-new condition.
Close Up: Cleaning caked-up polish from job trays is a near-impossible task. Alternatives such as tray inserts, industrial washing machines, or replacing dirty job trays have been the only available options. With OptiSource’s new formula, the lifetime of a job tray is extended and the problem of scratching lenses from built-up polish is finally eliminated. The new Job Tray Cleaner works instantly by using a simple spread-on and wipe-off process, and is good for both traditional and robotic-style job trays.
“Scratched lenses are a prolific pain-point for any surfacing customer,” said Daryl Squicciarini, president of OptiSource. “Our Job Tray Cleaner eliminates one more variable contributing to scratched lens remakes.”
Vital Stats: The new formula has been specially developed not only to remove dried polish from job trays, but also from any other polish-laden surface, making it a must-have for all labs.
www.1-800-OptiSource.com; (800) 678-4768


Top Send your comments to VM

BACK TO TOP

Send Us Your News & Ideas

Andrew Karp, Group Editor, Lenses and Technology

Send us news about developments in dispensing technology, lens processing equipment, software, diagnostic and web technology. Or provide us with subjects for future stories or topics you'd like to see covered. Contact VMail Technology’s Editor Andrew Karp at akarp@jobson.com.


VMail Technology is a service of Jobson Medical Information LLC, the publisher of VisionMonday®,
440 Ninth Ave, 14th Floor, New York NY 10001.

If you do not wish to receive future VMail Technology e-mails, please click UNSUBSCRIBE.

© 2018 Jobson Medical Information LLC All Rights Reserved EyesWay content is developed, sourced and
reported by the editors of EyesWay, the international news portal. VMail provides that content to its
subscribers as part of an exclusive news exchange agreement.